Genetic Engineering and Nanotechnology: Advanced

This is the final stage of the Ucanly Genetic Engineering and Nanotechnology track, where research scientists become principal investigators. Built for practitioners with hands on experience designing genome editing or nanomedicine research with real scientific accountability, this program goes deep into advanced therapeutic modalities including gene therapy, cell therapy, and mRNA platforms, and AI driven computational design with RFdiffusion, ProteinMPNN, and AlphaFold Multimer. You will engineer advanced delivery and formulation systems, including LNP formulation and endosomal escape, and build translational science skills covering the preclinical pathway, toxicology, and biomarkers. In your week six minor project, you will build a complete translational and regulatory package for a nanomedicine candidate, including CMC and QbD strategy, a preclinical pathway, a biosafety dossier, and an IP position, defended before a simulated regulatory and biosafety panel. You will also build research leadership skills: grant writing, patent strategy, publication strategy, and biotech translation into spinouts. All laboratory work in this program is simulated or in silico, conducted entirely within biosafety and bioethics frameworks, and this program teaches responsible, regulated, and ethical research practice only. You will graduate having architected a full principal investigator grade research program in your week twelve major project, with an AI designed therapeutic, a platform strategy, a translational roadmap, a funding proposal and budget, an ethics and governance framework, and a live grant panel defense.